GSK closes acquisition of Tesaro for $5.1bn

GSK closes acquisition of Tesaro for $5.1bn

Submitted by admin on January 23, 2019 - 10:39am
Source: 
Pharmaceutical Business Review
News Tags: 
GSK
Tesaro
M&A
oncology
Headline: 
GSK closes acquisition of Tesaro for $5.1bn
snippet: 


British drugmaker GlaxoSmithKline (GSK) has completed the acquisition of the US-based oncology-focused biopharmaceutical firm Tesaro for $5.1bn (£4bn). Tesaro acquisition will enable GSK to strengthen its pharmaceutical business; and expand its pipeline and commercial capability in oncology.

Do Not Allow Advertisers to Use My Personal information